Related Experiment Video
Updated: Oct 18, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cost-utility analysis of pacemakers for the treatment of vasovagal syncope
C R Mitton1, M S Rose, M L Koshman
1Health Research Group, University of Calgary, Alberta, Canada.
Abstract:
Dual-chamber pacing is a promising treatment for patients with very frequent vasovagal syncope, but its cost utility is unknown. We report that the incremental cost per quality-adjusted life-year gained is $13,159 Canadian dollars (about $8,600 US dollars), and therefore this pacemaker therapy for vasovagal syncope has a favorable cost-utility ratio.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Mitral Regurgitation III: Medical Management
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Mitral Stenosis III: Medical Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Aortic Regurgitation III: Medical Management

